Cargando…
Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790742/ https://www.ncbi.nlm.nih.gov/pubmed/35095916 http://dx.doi.org/10.3389/fimmu.2021.815812 |
| _version_ | 1784640083020742656 |
|---|---|
| author | Moreira, Thais G. Matos, Kimble T. F. De Paula, Giovana S. Santana, Thais M. M. Da Mata, Raquel G. Pansera, Fernando C. Cortina, Andre S. Spinola, Marcelle G. Baecher-Allan, Clare M. Keppeke, Gerson D. Jacob, Jules Palejwala, Vaseem Chen, Karen Izzy, Saef Healey, Brian C. Rezende, Rafael M. Dedivitis, Rogerio A. Shailubhai, Kunwar Weiner, Howard L. |
| author_facet | Moreira, Thais G. Matos, Kimble T. F. De Paula, Giovana S. Santana, Thais M. M. Da Mata, Raquel G. Pansera, Fernando C. Cortina, Andre S. Spinola, Marcelle G. Baecher-Allan, Clare M. Keppeke, Gerson D. Jacob, Jules Palejwala, Vaseem Chen, Karen Izzy, Saef Healey, Brian C. Rezende, Rafael M. Dedivitis, Rogerio A. Shailubhai, Kunwar Weiner, Howard L. |
| author_sort | Moreira, Thais G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8790742 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87907422022-01-27 Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study Moreira, Thais G. Matos, Kimble T. F. De Paula, Giovana S. Santana, Thais M. M. Da Mata, Raquel G. Pansera, Fernando C. Cortina, Andre S. Spinola, Marcelle G. Baecher-Allan, Clare M. Keppeke, Gerson D. Jacob, Jules Palejwala, Vaseem Chen, Karen Izzy, Saef Healey, Brian C. Rezende, Rafael M. Dedivitis, Rogerio A. Shailubhai, Kunwar Weiner, Howard L. Front Immunol Immunology Frontiers Media S.A. 2022-01-12 /pmc/articles/PMC8790742/ /pubmed/35095916 http://dx.doi.org/10.3389/fimmu.2021.815812 Text en Copyright © 2022 Moreira, Matos, De Paula, Santana, Da Mata, Pansera, Cortina, Spinola, Baecher-Allan, Keppeke, Jacob, Palejwala, Chen, Izzy, Healey, Rezende, Dedivitis, Shailubhai and Weiner https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Moreira, Thais G. Matos, Kimble T. F. De Paula, Giovana S. Santana, Thais M. M. Da Mata, Raquel G. Pansera, Fernando C. Cortina, Andre S. Spinola, Marcelle G. Baecher-Allan, Clare M. Keppeke, Gerson D. Jacob, Jules Palejwala, Vaseem Chen, Karen Izzy, Saef Healey, Brian C. Rezende, Rafael M. Dedivitis, Rogerio A. Shailubhai, Kunwar Weiner, Howard L. Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study |
| title | Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study |
| title_full | Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study |
| title_fullStr | Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study |
| title_full_unstemmed | Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study |
| title_short | Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study |
| title_sort | corrigendum: nasal administration of anti-cd3 monoclonal antibody (foralumab) reduces lung inflammation and blood inflammatory biomarkers in mild to moderate covid-19 patients: a pilot study |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790742/ https://www.ncbi.nlm.nih.gov/pubmed/35095916 http://dx.doi.org/10.3389/fimmu.2021.815812 |
| work_keys_str_mv | AT moreirathaisg corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT matoskimbletf corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT depaulagiovanas corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT santanathaismm corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT damataraquelg corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT panserafernandoc corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT cortinaandres corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT spinolamarcelleg corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT baecherallanclarem corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT keppekegersond corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT jacobjules corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT palejwalavaseem corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT chenkaren corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT izzysaef corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT healeybrianc corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT rezenderafaelm corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT dedivitisrogerioa corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT shailubhaikunwar corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy AT weinerhowardl corrigendumnasaladministrationofanticd3monoclonalantibodyforalumabreduceslunginflammationandbloodinflammatorybiomarkersinmildtomoderatecovid19patientsapilotstudy |